Supergut is already very well-positioned for this Ozempic era, and were seeing a significant surge in demand from consumers looking for a natural approach to curb cravings, support health weight management, and nourish your gut for improved digestive health. But the surge in popularity also brings about one of the brands biggest obstacles: scaling up operations and supply chains to keep up with the demand
The study reported lower risks for several cancers, including hepatocellular, colorectal, breast, and prostate cancers, though it did not find a significant reduction in lung cancer risk.25 So the honest answer is this: current human evidence does not show that NAC causes cancer, but animal and mechanistic research suggests NAC could behave differently depending on cancer type, disease stage, dose, and treatment context
"These situations are very personal decisions that depend on a woman's medical condition, depend on the timing and the choice of medication that she's taking, and these should always, always, always be discussed with that woman's own prescribing clinician." Saunders also said tirzepatide, sold under the brand names Mounjaro and Zepbound, carries an FDA warning about use with oral birth control
We have seen that costs associated with GLP-1 agonists are continuing to rise, and cost-based decisions are being made by public and private insurers, as well as employers as utilization increases and organizations work to manage or contain costs, added Glaze-Rowe
Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors
As with any peptide, understanding the mechanism is only the first step